Jornal Vascular Brasileiro
https://www.jvascbras.org/article/doi/10.1590/1677-5449.202401722
Jornal Vascular Brasileiro
Brief Communication

Cost of radiofrequency ablation for chronic venous insufficiency: a pilot study of 9 cases at a teaching hospital in Brazil

Custo da ablação por radiofrequência para insuficiência venosa crônica: estudo piloto de nove casos em um hospital universitário no Brasil

Ana Luiza Carvalho Sartoreli; Henrique Capistrano dos Santos; Thais Keltke Santos Felippe; Júlio César Souza Diniz; Luiz Baldini Neto; Gustavo Muçouçah Sampaio Brandão; Michel Nasser

Downloads: 0
Views: 9

Abstract

Background: While radiofrequency ablation (RFA) is increasingly used to treat saphenous vein incompetence, its adoption in Brazil may have been hindered by the lack of evidence demonstrating sufficient added value to justify its cost-effectiveness.

Objectives: To perform RFA in 9 patients with lower extremity varicose veins and determine the procedural costs per patient at a Brazilian teaching hospital.

Methods: Nine single-use RFA catheters were purchased by the teaching hospital affiliated with our institution and used in this pilot study. Direct and indirect costs were calculated as sums of the respective cost components of the procedure based on values from the federal government’s price panel. To illustrate the potential cost-effectiveness of RFA, these costs were compared to those of 9 saphenectomy procedures performed on the same day as the RFA procedures. All analyses were descriptive, with no formal statistical testing.

Results: The mean operating room hourly rate for RFA was 127.50 BRL. The costs of anesthetics/medications, materials, and single-use catheter per patient were 32.63 BRL, 81.49 BRL, and 1600.00 BRL, respectively. Patients were absent from work for < 15 days (mean, 11.44 days), not incurring sick leave payments from the Social Security Administration. The total mean cost for RFA was lower than that of same-day saphenectomy (1841.62 BRL vs 2045.40 BRL).

Conclusions: This pilot study provided essential insights into resource utilization at a Brazilian teaching hospital, with the goal of improving treatment efficiency and ensuring the best cost-benefit ratio for patients.

Supplementary material

Keywords

chronic venous disease; varicose veins; saphenectomy; radiofrequency ablation; cost-effectiveness; teaching hospital

Resumo

Contexto: Embora a ablação por radiofrequência (ARF) seja cada vez mais utilizada no tratamento de insuficiência da veia safena, sua adoção no Brasil pode ter sido dificultada pela falta de evidências que demonstrem um valor agregado suficiente para justificar sua relação custo-efetividade.

Objetivos: Avaliar a ARF em nove pacientes com varizes de membros inferiores e determinar os custos do procedimento por paciente em um hospital universitário brasileiro.

Métodos: Nove cateteres de ARF de uso único adquiridos pelo hospital universitário afiliado à nossa instituição foram utilizados neste estudo piloto. Os custos diretos e indiretos foram calculados como somas dos respectivos componentes de custo do procedimento, segundo valores do painel de preços do governo federal. Para ilustrar o potencial custo-benefício da ARF, esses custos foram comparados aos de nove safenectomias realizadas no mesmo dia das ARFs. As análises foram descritivas, sem aplicação de testes estatísticos formais.

Resultados: A taxa horária média da sala cirúrgica para ARF foi de R$ 127,50. Os custos com anestésicos/medicamentos, materiais e cateter por paciente foram de R$ 32,63, R$ 81,49 e R$ 1.600,00, respectivamente. Os pacientes se ausentaram do trabalho por < 15 dias (média: 11,44 dias), não incorrendo em pagamentos de licença médica pelo Instituto Nacional do Seguro Social. O custo médio total da ARF foi menor do que o da safenectomia no mesmo dia (R$ 1.841,62 vs. R$ 2.045,40).

Conclusões: Este estudo piloto forneceu dados essenciais sobre a utilização de recursos em um hospital universitário brasileiro, com o objetivo de melhorar a eficiência do tratamento e garantir a melhor relação custo-benefício para os pacientes.

Material suplementar

Palavras-chave

doença venosa crônica; varizes; safenectomia; ablação por radiofrequência; custo-efetividade; hospital universitário

References

1 Gloviczki P, Comerota AJ, Dalsing MC, et al. The care of patients with varicose veins and associated chronic venous diseases: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. J Vasc Surg. 2011;53(5, Suppl):2S-48S. http://doi.org/10.1016/j.jvs.2011.01.079. PMid:21536172.

2 Maffei FHA. Doenças vasculares periféricas. Rio de Janeiro: Guanabara Koogan; 2015.

3 Jameson JL, Fauci A, Kasper D, Hauser S, Longo D, Loscalzo J. Harrison’s principles of internal medicine. 20th ed. New York: McGraw-Hill Education; 2018.

4 Santler B, Goerge T. Chronic venous insufficiency: a review of pathophysiology, diagnosis, and treatment. J Dtsch Dermatol Ges. 2017;15(5):538-56. http://doi.org/10.1111/ddg.13242.

5 Rabe E, Guex JJ, Puskas A, Scuderi A, Fernandez Quesada F. Epidemiology of chronic venous disorders in geographically diverse populations: results from the Vein Consult Program. Int Angiol. 2012;31(2):105-15. PMid:22466974.

6 Sidawy AP, Perler BA, editors. Rutherford’s vascular surgery and endovascular therapy. 9th ed. Amsterdam: Elsevier; 2019.

7 Pereira AFA, Mesquita A, Gomes C. Abordagens cirúrgicas no tratamento de varizes. Angiol Cir Vasc. 2014;10(3):132-40. http://doi.org/10.1016/j.ancv.2014.08.003.

8 De Maeseneer MG, Kakkos SK, Aherne T, et al. Editor’s Choice - European Society for Vascular Surgery (ESVS) 2022 clinical practice guidelines on the management of chronic venous disease of the lower limbs. Eur J Vasc Endovasc Surg. 2022;63(2):184-267. http://doi.org/10.1016/j.ejvs.2021.12.024. PMid:35027279.

9 Gohel MS, Epstein DM, Davies AH. Cost-effectiveness of traditional and endovenous treatments for varicose veins. Br J Surg. 2010;97(12):1815-23. http://doi.org/10.1002/bjs.7256. PMid:20922783.

10 Aherne TM, Ryan ÉJ, Boland MR, et al. Concomitant vs. staged treatment of varicose tributaries as an adjunct to endovenous ablation: a systematic review and meta-analysis. Eur J Vasc Endovasc Surg. 2020;60(3):430-42. http://doi.org/10.1016/j.ejvs.2020.05.028. PMid:32771286.

11 Jin HY, Ohe HJ, Hwang JK, et al. Radiofrequency ablation of varicose veins improves venous clinical severity score despite failure of complete closure of the saphenous vein after 1 year. Asian J Surg. 2017;40(1):48-54. http://doi.org/10.1016/j.asjsur.2016.03.004. PMid:27378121.

12 Epstein D, Onida S, Bootun R, Ortega-Ortega M, Davies AH. Cost-effectiveness of current and emerging treatments of varicose veins. Value Health. 2018;21(8):911-20. http://doi.org/10.1016/j.jval.2018.01.012. PMid:30098668.

13 Poder TG, Fisette JF, Bédard SK, Despatis MA. Is radiofrequency ablation of varicose veins a valuable option? A systematic review of the literature with a cost analysis. Can J Surg. 2018;61(2):128-38. http://doi.org/10.1503/cjs.010114. PMid:29582749.

14 Epstein D, Bootun R, Diop M, Ortega-Ortega M, Lane TRA, Davies AH. Cost-effectiveness analysis of current varicose veins treatments. J Vasc Surg Venous Lymphat Disord. 2022;10(2):504-513.e7. http://doi.org/10.1016/j.jvsv.2021.05.014. PMid:34450353.

15 Brasil. Ministério da Gestão e da Inovação em Serviços Públicos. Painel de Preços [Internet]. Brasília; 2024 [citado 2024 dec 20]. https://paineldeprecos.planejamento.gov.br/

16 Lurie F, Passman M, Meisner M, et al. The 2020 update of the CEAP classification system and reporting standards. J Vasc Surg Venous Lymphat Disord. 2020;8(3):342-52. http://doi.org/10.1016/j.jvsv.2019.12.075. PMid:32113854.

17 Carroll C, Hummel S, Leaviss J, et al. Systematic review, network meta-analysis and exploratory cost-effectiveness model of randomized trials of minimally invasive techniques versus surgery for varicose veins. Br J Surg. 2014;101(9):1040-52. http://doi.org/10.1002/bjs.9566. PMid:24964976.

18 Ferreira MB, Galego GDN, Nazário NO, et al. Use of 1,470 nm laser for treatment of superficial venous insufficiency. J Vasc Bras. 2021;20:e20200244. http://doi.org/10.1590/1677-5449.200244. PMid:34290757.
 


Submitted date:
12/20/2024

Accepted date:
04/14/2025

Sociedade Brasileira de Angiologia e Cirurgia Vascular (SBACV)"> Sociedade Brasileira de Angiologia e Cirurgia Vascular (SBACV)">
68657c8da953956bf7409c55 jvb Articles
Links & Downloads

J Vasc Bras

Share this page
Page Sections